Upstream Bio

Acquisition, funding and merger involving Upstream Bio.

• Upstream Bio has just announced a $200 Million fundraising (posted on June 12 2023).

View the org chart displaying its 20 main executives

Most searched biographies at Upstream Bio

• Rand Sutherland, Chief Executive Officer
• Ron Renaud, Chairman of the Board
• Marcella Ruddy, Director

Popular executive movements at Upstream Bio

• Rand Sutherland has joined the company as Chief Executive Officer  (posted on April 3 2024).
• Mike Gray has joined the company as Chief Financial Officer and Chief Operating Officer  (posted on April 3 2024).
• Lisa Fiering has joined the company as Senior Vice President, People and Culture  (posted on April 3 2024).

Create your alert
to follow the executive moves at Upstream Bio.

Upstream Bio has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Upstream Bio

• Upstream Bio raises $200M in fresh funding for asthma drug
• https://www.upstreambio.com/s/Upstream-FINAL-FPI-Press-release.pdf

Social media about Upstream Bio

• Upstream Bio on Wikipedia, Google News & Yahoo Finance
• Upstream Bio on LinkedIn, Twitter & YouTube

Contact by email its executives including Rand Sutherland

Call Upstream Bio at +1 590...

View the org chart

Register to receive your alert

Report an error